2 New Surgeons Join Division of Solid Organ Transplantation

Christopher Barry, M.D., Ph.D.

The University of Rochester Medical Center’s Department of Surgery welcomes two surgeons to its Division of Solid Organ Transplantation: Christopher Taylor Barry, M.D., Ph.D., and Carlos E. Marroquin, M.D. Both begin Aug. 3.

“I am proud to welcome these two impressive surgeons to our growing faculty,” said Jeffrey H. Peters, M.D., Seymour I. Schwartz Professor and chair of the URMC Department of Surgery. “As surgical specialists and researchers, they fit perfectly into the vision of the Medical Center’s Strategic Plan.”

Barry and Marroquin join veteran surgeon Mark S. Orloff, M.D., professor of Surgery, chief of the Division of Solid Organ Transplantation and director of Live Donor Liver Transplant, and Randeep S. Kashyap, M.D., assistant professor of Surgery.

Carlos E. Marroquin, M.D.

“The addition of Chris and Carlos to our transplant team, with their clinical and research expertise in the areas of renal and liver transplant, will further enable us to provide the very best care for our patients,” Orloff said.

Barry, most recently an assistant professor in residence in the Department of General Surgery/Section of Transplantation at UC-San Diego, specializes in liver, kidney and pancreas transplantation, as well as laparoscopic removal of kidneys from healthy living donors. He performs traditional and laparoscopic resections and laparoscopic radiofrequency ablation of liver tumors. He has research interests in liver cancer and employs genomic analysis (the study of the entire genome to determine which genes are on and which are off) to better understand the prognosis and best treatment options for an individual patient's liver tumor. To learn more about Barry, click here.

Marroquin, most recently an assistant professor in Duke University Medical Center’s Department of Surgery, specializes in abdominal solid organ transplantation and hepatobiliary surgery, with a special interest in laparoscopy both for kidney retrieval and applications to the management of hepatocellular carcinoma (HCC). In addition to developing new algorithms for the treatment of HCC, his research interests include the evolution of tolerance and innovative strategies to transplanting sensitized patients. He will be the surgical director of kidney and pancreas transplantation and bring a number of these strategies to an expanded effort in the treatment of renal failure. To learn more about Marroquin, click here.